BrainSee Covered by Medicare

BrainSee is an innovative platform offering the first fully non-invasive, FDA-approved test for assessing the likelihood of progression to Alzheimer’s disease (AD) dementia over the next five years.

Address

Online
San Francisco, CA
94158

Alerts

Be the first to know and let us send you an email when BrainSee posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BrainSee:

Shortcuts

Share